LCM
WGS icon

Legato Capital Management’s GeneDx Holdings WGS Stock Holding History

Legato Capital Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,240
Closed -$1.33M – 889
2025
Q4 		$1.33M Buy
10,240
+440
+4% +$60.4K 0.11% 285
2025
Q3 		$1.06M Sell
9,800
-935
-9% -$102K 0.12% 276
2025
Q2 		$991K Sell
10,735
-12,552
-54% -$985K 0.12% 276
2025
Q1 		$2.06M Sell
23,287
-4,404
-16% -$382K 0.28% 95
2024
Q4 		$2.13M Buy
27,691
+12,961
+88% +$905K 0.28% 87
2024
Q3 		$625K Buy
+14,730
New +$498K 0.08% 401

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Legato Capital Management's WGS Position: Q1 2026 in Review

Legato Capital Management sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 10,240 shares — an estimated $1.33M sold.

Legato Capital Management first reported a position in WGS in Q3 2024 and held it in 6 quarters. The position peaked at $2.13M in Q4 2024. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Legato Capital Management reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
  • Legato Capital Management sold 10,240 GeneDx Holdings shares in Q1 2026, an estimated $1.33M.
  • Legato Capital Management first reported a position in GeneDx Holdings in Q3 2024 and held it in 6 quarters.
  • Legato Capital Management's GeneDx Holdings position peaked at $2.13M in Q4 2024.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.